By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Curis, Inc. 

61 Moulton Street

Cambridge  Massachusetts  02138  U.S.A.
Phone: 617-876-0086 Fax: 617-876-0866



Company News
Curis, Inc. (CRIS) To Present At Upcoming Investor Conference 8/27/2014 8:33:10 AM
Curis, Inc. (CRIS) Reports Second Quarter 2014 Financial Results 8/7/2014 8:06:15 AM
Curis, Inc. (CRIS) To Release Second Quarter 2014 Financial Results And Hold Conference Call On August 7, 2014 7/31/2014 10:18:25 AM
Curis, Inc. (CRIS) Announces Investigational New Drug Application Filing By Roche (RHHBY) To Initiate A Phase 2 Study Of Erivedge® (Vismodegib) In Idiopathic Pulmonary Fibrosis 6/23/2014 7:47:43 AM
Curis, Inc. (CRIS) To Present At The JMP Securities Healthcare Conference 6/18/2014 8:34:37 AM
Curis, Inc. (CRIS) Announces Re-Initiation Of Patient Dosing In CUDC-427 Monotherapy Clinical Trial 6/5/2014 9:27:25 AM
Curis, Inc. (CRIS) Appoints A New CEO 6/3/2014 9:13:09 AM
Curis, Inc. (CRIS) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 9:38:35 AM
Curis, Inc. (CRIS) Announces Abstracts For Its Partnered Programs, Erivedge(R) And Debio 0932 To Be Presented At The 2014 American Society of Clinical Oncology Annual Meeting 5/23/2014 10:18:09 AM
Curis, Inc. (CRIS) Reports First Quarter 2014 Financial Results 5/8/2014 9:29:09 AM